Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder
Condition(s):ADHD Predominantly Inattentive TypeLast Updated:January 14, 2014Completed
Hide Studies Not Open or Pending
Condition(s):ADHD Predominantly Inattentive TypeLast Updated:January 14, 2014Completed
Condition(s):ADHD – Inattentive Type; ADHD – Combined TypeLast Updated:May 18, 2021Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:February 21, 2022Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:April 30, 2013Completed
Condition(s):ADHD Predominantly Inattentive TypeLast Updated:March 12, 2024Active, not recruiting
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:June 18, 2019Completed
Condition(s):ADHD, Predominantly Inattentive TypeLast Updated:March 4, 2015Completed
Condition(s):Inattentive; Hyperactivity; ImpulsivityLast Updated:December 27, 2022Completed
Condition(s):ADHDLast Updated:September 18, 2019Completed
Condition(s):Attention Deficit Hyperactivity Disorder; ADHDLast Updated:June 15, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.